Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zakaria Einbeigi

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Cancer Nursing|December 24, 2008
Psychological reactions to progression of metastatic breast cancer--an interview studyHelene Svensson, Yvonne Brandberg, Zakaria Einbeigi, et al.
Medical Oncology (Northwood, London, England)|February 8, 2011
Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancerHelene Svensson, Thomas Hatschek, Hemming Johansson, et al.
Breast Cancer Research and Treatment|August 4, 2010
Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)Helene Svensson, Zakaria Einbeigi, Hemming Johansson, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2010
BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care regionZakaria Einbeigi, Charlotta Enerbäck, Arne Wallgren, et al.
Genes|January 1, 2020
Increased Overall Mortality Even after Risk Reducing Surgery for <i>BRCA</i>-Positive Women in Western SwedenAnna Öfverholm, Zakaria Einbeigi, Antonia Wigermo, et al.
Acta Oncologica (Stockholm, Sweden)|August 5, 2024
Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathyJamila Adra, Daniel Giglio, Per Karlsson, et al.
BMC Cancer|March 25, 2022
Pan-cancer analysis identifies BIRC5 as a prognostic biomarkerAnna Fäldt Beding, Peter Larsson, Khalil Helou, et al.
Oncology Letters|September 12, 2012
The ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicityAnna Ofverholm, Zakaria Einbeigi, Shokoufeh Manouchehrpour, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Clustering of individuals with both breast and ovarian cancer--a possible indicator of BRCA founder mutationsZakaria Einbeigi, Jeanne M Meis-Kindblom, Lars-Gunnar Kindblom, et al.
BMC Cancer|February 5, 2013
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancerEmman Shubbar, Khalil Helou, Anikó Kovács, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Cancer Nursing|December 24, 2008
Psychological reactions to progression of metastatic breast cancer--an interview studyHelene Svensson, Yvonne Brandberg, Zakaria Einbeigi, et al.
Medical Oncology (Northwood, London, England)|February 8, 2011
Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancerHelene Svensson, Thomas Hatschek, Hemming Johansson, et al.
Breast Cancer Research and Treatment|August 4, 2010
Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)Helene Svensson, Zakaria Einbeigi, Hemming Johansson, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2010
BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care regionZakaria Einbeigi, Charlotta Enerbäck, Arne Wallgren, et al.
Genes|January 1, 2020
Increased Overall Mortality Even after Risk Reducing Surgery for <i>BRCA</i>-Positive Women in Western SwedenAnna Öfverholm, Zakaria Einbeigi, Antonia Wigermo, et al.
Acta Oncologica (Stockholm, Sweden)|August 5, 2024
Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathyJamila Adra, Daniel Giglio, Per Karlsson, et al.
BMC Cancer|March 25, 2022
Pan-cancer analysis identifies BIRC5 as a prognostic biomarkerAnna Fäldt Beding, Peter Larsson, Khalil Helou, et al.
Oncology Letters|September 12, 2012
The ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicityAnna Ofverholm, Zakaria Einbeigi, Shokoufeh Manouchehrpour, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Clustering of individuals with both breast and ovarian cancer--a possible indicator of BRCA founder mutationsZakaria Einbeigi, Jeanne M Meis-Kindblom, Lars-Gunnar Kindblom, et al.
BMC Cancer|February 5, 2013
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancerEmman Shubbar, Khalil Helou, Anikó Kovács, et al.
Pageof 5